Hubei Biocause Heilen Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Qun Liang
Chief executive officer
CN¥404.2k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.4yrs |
| CEO ownership | n/a |
| Management average tenure | 4.4yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Qun Liang (53 yo)
4.4yrs
Tenure
CN¥404,200
Compensation
Mr. Qun Liang is General Manager of Hubei Biocause Heilen Pharmaceutical Co., Ltd. from June 2020.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager | 4.4yrs | CN¥404.20k | no data | |
| Financial Director | 4.4yrs | CN¥396.70k | no data | |
| Board Secretary | 2.5yrs | CN¥402.10k | no data | |
| Deputy General Manager | 4.4yrs | CN¥358.80k | no data |
4.4yrs
Average Tenure
51.5yo
Average Age
Experienced Management: 301211's management team is considered experienced (4.4 years average tenure).